Investigation of the Cardiovascular Effects of Exenatide in Healthy Male Subjects.

Trial Profile

Investigation of the Cardiovascular Effects of Exenatide in Healthy Male Subjects.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Apr 2016

At a glance

  • Drugs Exenatide (Primary)
  • Indications Non-alcoholic steatohepatitis; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 09 Feb 2012 Results published in the British Journal of Clinical Pharmacology.
    • 02 Jun 2010 Planned end date changed from 1 Jan 2010 to 1 Sep 2010 Last checked against ClinicalTrials.gov record.
    • 19 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top